GMP-compliant iPS cell lines show widespread plasticity in a new set of differentiation workflows for cell replacement and cancer immunotherapy
符合 GMP 标准的 iPS 细胞系在用于细胞替代和癌症免疫治疗的一系列新分化工作流程中表现出广泛的可塑性
期刊:Stem Cells Translational Medicine
影响因子:5.4
doi:10.1093/stcltm/szae047
Daniel Terheyden-Keighley, Melanie Hühne, Thomas Berger, Björn Hiller, Soraia Martins, Anna Gamerschlag, Davood Sabour, Andrea Meffert, Andreas Kislat, Carsten Slotta, Francois Hafezi, Jens Lichte, Smita Sudheer, Karen Tessmer, Katherina Psathaki, Marius Ader, Gesine Kogler, Boris Greber